2-叠氮环己烯 | 51453-77-1

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 中文名称: 2-叠氮环己烯
• 英文名称: 2-azidocyclohexene
• 英文别名: 1-Azido-1-cyclohexen；1-Azido-cyclohexen；1-Azidocyclohexen；1-Azidocyclohex-1-ene；1-azidocyclohexene
• CAS: 51453-77-1
• 化学式: C₆H₉N₃
• 分子量: 123.158
• InChiKey: FXGLOLPRKZZOHD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  14.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-叠氮环己烯 在 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 生成 6-氧代己腈
  参考文献：
  名称：

  Schweng,J.; Zbiral,E., Justus Liebigs Annalen der Chemie, 1978, p. 1089 - 1095

  摘要：

  DOI：
• 作为产物：
  描述：

  trans-2-azido-1-cyclohexanol 在 potassium tert-butylate 、 溴化乙啶 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 乙醚 、 苯 为溶剂， 生成 2-叠氮环己烯
  参考文献：
  名称：

  Schweng,J.; Zbiral,E., Justus Liebigs Annalen der Chemie, 1978, p. 1089 - 1095

  摘要：

  DOI：

文献信息

• Phenylselenium azide addition to alkenes. A new and stereospecific introduction of Se and N into organic molecules.
  作者：Alfred Hassner、Ananda S. Amarasekara

  DOI：10.1016/s0040-4039(00)95624-7

  日期：——

  The first examples of direct introduction of PhSe and N3 functions by addition to olefins are reported. The addition of PhSeN3 to simple alkenes, as well as to activated alkenes takes place in the absence of a catalyst. The reaction proceeds stereospecifically but not regiospecifically, apparently via a 3-membered selenonium ion intermediate.

  报道了通过添加烯烃直接引入PhSe和N 3官能团的第一个实例。在没有催化剂的情况下，将PhSeN 3加到简单的烯烃以及活化的烯烃中。该反应显然是立体定向的，而不是区域特异性的，显然是通过一个三元硒离子中间体进行的。
• AMINOCYCLITOL COMPOUNDS, PROCESS FOR OBTAINING THEM AND USES
  申请人：Llebaria Soldevilla Amadeo

  公开号：US20120093875A1

  公开（公告）日：2012-04-19

  Aminocyclitol compounds and uses thereof as pharmaceutical compositions for the treatment of diseases associated with alterations in iNKT cells, more specifically autoimmune diseases, cancer, infections caused by pathogenic microorganisms or inflammatory diseases. Furthermore, the invention relates to the process for obtaining said compounds.

  氨基环糖醇化合物及其用途作为制药组合物治疗与iNKT细胞变化相关的疾病，更具体地包括自身免疫性疾病、癌症、由致病微生物引起的感染或炎症性疾病。此外，本发明还涉及获得该化合物的过程。
• Aminocyclohexanes as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
  申请人：Biftu Tesfaye

  公开号：US20090270467A1

  公开（公告）日：2009-10-29

  The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及结构式（I）的新型取代氨基环己烷，其是二肽基肽酶-IV酶的抑制剂，并且对于涉及二肽基肽酶-IV酶的疾病的治疗或预防，例如糖尿病，特别是2型糖尿病，具有用途。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及二肽基肽酶-IV酶的疾病中的使用。
• TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
  申请人：Cox Jason M.

  公开号：US20100056550A1

  公开（公告）日：2010-03-04

  The present invention is directed to novel substituted tricyclic heteroaromatic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及结构式(I)的新型取代三环杂芳烃化合物，其为二肽基肽酶-IV酶的抑制剂，可用于治疗或预防二肽基肽酶-IV酶参与的疾病，如糖尿病，特别是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗二肽基肽酶-IV酶参与的此类疾病中使用这些化合物和组合物的方法。
• Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes
  申请人：Biftu Tesfaye

  公开号：US20090105284A1

  公开（公告）日：2009-04-23

  The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及一种新型的取代氨基环己烷化合物，它们是二肽基肽酶-IV酶（“DPP-IV抑制剂”）的抑制剂，可用于治疗或预防二肽基肽酶-IV酶参与的疾病，如糖尿病，特别是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗二肽基肽酶-IV酶参与的疾病中使用这些化合物和组合物的方法。